Engineered DNA can store massive amounts of data while also encrypting it, opening the door to ultra-secure, long-term ...
A major breakthrough in cancer drug delivery took place in 1995, when the FDA approved the first nanodrug, Doxil—a liposomal formulation of doxorubicin engineered to preferentially accumulate in ...
Uncovering complex disease patterns from large-scale, heterogeneous health data remains a significant challenge. Traditional statistical methods and conventional machine learning algorithms often ...
A new study from MIT suggests the biggest and most computationally intensive AI models may soon offer diminishing returns compared to smaller models. By mapping scaling laws against continued ...
In the five years since Italy-based Chiesi Group established its rare disease division in Boston, the unit has landed regulatory approvals worldwide for 10 therapies — all small molecules and ...
Abstract: The conventional model predictive current control (MPCC) for permanent magnet synchronous motor (PMSM) is affected by the issues of stator current fluctuation and control performance ...
UC Santa Barbara researchers and collaborators from campus biotech spinoff Integrated Biosciences, as well as Harvard, MIT, Princeton and genomics company Illumina Ventures are using optogenetics — ...
Fruit ripening determines shelf life and consumer appeal, yet the molecular switches that control this process remain partially understood. This study identifies a key regulator—histone deacetylase ...
Researchers have found a promising new method for gene therapy. They successfully restarted inactive genes by bringing them closer to genetic switches on the DNA called enhancers. The intermediate ...
Proteogenomics explores how genetic information translates into protein expression and function, and the role of changes across DNA, RNA, and proteins in influencing disease development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results